Recently, increased sensitivity to in vitro IL-4 stimulation as measured by enhanced expression of the low-affinity IgE receptor (CD23) on B cells was observed in ABPA patients [43, 44]. The gene discussed is FCER2; the disease is allergic bronchopulmonary aspergillosis.